Literature DB >> 30085657

A Commensal Dipeptidyl Aminopeptidase with Specificity for N-Terminal Glycine Degrades Human-Produced Antimicrobial Peptides in Vitro.

Janice H Xu1, Zhenze Jiang2, Angelo Solania1, Sandip Chatterjee1, Brian Suzuki2, Christopher B Lietz2, Vivian Y H Hook2, Anthony J O'Donoghue2, Dennis W Wolan1.   

Abstract

Proteases within the C1B hydrolase family are encoded by many organisms. We subjected a putative C1B-like cysteine protease secreted by the human gut commensal Parabacteroides distasonis to mass spectrometry-based substrate profiling to find preferred peptide substrates. The P. distasonis protease, which we termed Pd_dinase, has a sequential diaminopeptidase activity with strong specificity for N-terminal glycine residues. Using the substrate sequence information, we verified the importance of the P2 glycine residue with a panel of fluorogenic substrates and calculated kcat and KM for the dipeptide glycine-arginine-AMC. A potent and irreversible dipeptide inhibitor with a C-terminal acyloxymethyl ketone warhead, glycine-arginine- AOMK, was then synthesized and demonstrated that the Pd_dinase active site requires a free N-terminal amine for potent and rapid inhibition. We next determined the homohexameric Pd_dinase structure in complex with glycine-arginine- AOMK and uncovered unexpected active site features that govern the strict substrate preferences and differentiate this protease from members of the C1B and broader papain-like C1 protease families. We finally showed that Pd_dinase hydrolyzes several human antimicrobial peptides and therefore posit that this P. distasonis enzyme may be secreted into the extracellular milieu to assist in gut colonization by inactivation of host antimicrobial peptides.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30085657      PMCID: PMC7293822          DOI: 10.1021/acschembio.8b00420

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  50 in total

1.  Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a self-activating barley cysteine endoprotease.

Authors:  Michael T Bethune; Pavel Strop; Yinyan Tang; Ludvig M Sollid; Chaitan Khosla
Journal:  Chem Biol       Date:  2006-06

2.  Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities.

Authors:  Youngchool Choe; Francesco Leonetti; Doron C Greenbaum; Fabien Lecaille; Matthew Bogyo; Dieter Brömme; Jonathan A Ellman; Charles S Craik
Journal:  J Biol Chem       Date:  2006-03-06       Impact factor: 5.157

Review 3.  Bacterial proteases in IBD and IBS.

Authors:  Natalie Steck; Kerstin Mueller; Michael Schemann; Dirk Haller
Journal:  Gut       Date:  2011-09-07       Impact factor: 23.059

4.  A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.

Authors:  Richárd Róka; András Rosztóczy; Mathilde Leveque; Ferenc Izbéki; Ferenc Nagy; Tamás Molnár; János Lonovics; Rafael Garcia-Villar; Jean Fioramonti; Tibor Wittmann; Lionel Bueno
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03-02       Impact factor: 11.382

5.  Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids.

Authors:  Yayoi Kamata; Aya Taniguchi; Mami Yamamoto; Junko Nomura; Kazuhiko Ishihara; Hidenari Takahara; Toshihiko Hibino; Atsushi Takeda
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

6.  Post-translational heterocyclic backbone modifications in the 43-peptide antibiotic microcin B17. Structure elucidation and NMR study of a 13C,15N-labelled gyrase inhibitor.

Authors:  A Bayer; S Freund; G Jung
Journal:  Eur J Biochem       Date:  1995-12-01

7.  Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization.

Authors:  D Brömme; A B Rossi; S P Smeekens; D C Anderson; D G Payan
Journal:  Biochemistry       Date:  1996-05-28       Impact factor: 3.162

Review 8.  Protease inhibition as new therapeutic strategy for GI diseases.

Authors:  Nathalie Vergnolle
Journal:  Gut       Date:  2016-04-12       Impact factor: 23.059

9.  Membrane-Active Epithelial Keratin 6A Fragments (KAMPs) Are Unique Human Antimicrobial Peptides with a Non-αβ Structure.

Authors:  Judy T Y Lee; Guangshun Wang; Yu Tong Tam; Connie Tam
Journal:  Front Microbiol       Date:  2016-11-11       Impact factor: 5.640

10.  Fecal protease activity is associated with compositional alterations in the intestinal microbiota.

Authors:  Ian M Carroll; Tamar Ringel-Kulka; Laurent Ferrier; Michael C Wu; Jennica P Siddle; Lionel Bueno; Yehuda Ringel
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more
  4 in total

1.  Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions.

Authors:  Michael C Yoon; Angelo Solania; Zhenze Jiang; Mitchell P Christy; Sonia Podvin; Charles Mosier; Christopher B Lietz; Gen Ito; William H Gerwick; Dennis W Wolan; Gregory Hook; Anthony J O'Donoghue; Vivian Hook
Journal:  ACS Chem Biol       Date:  2021-08-20       Impact factor: 4.634

Review 2.  Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health.

Authors:  Jessica C Ezeji; Daven K Sarikonda; Austin Hopperton; Hailey L Erkkila; Daniel E Cohen; Sandra P Martinez; Fabio Cominelli; Tomomi Kuwahara; Armand E K Dichosa; Caryn E Good; Michael R Jacobs; Mikhail Khoretonenko; Alida Veloo; Alexander Rodriguez-Palacios
Journal:  Gut Microbes       Date:  2021 Jan-Dec

3.  Cathepsin B Dipeptidyl Carboxypeptidase and Endopeptidase Activities Demonstrated across a Broad pH Range.

Authors:  Michael C Yoon; Vivian Hook; Anthony J O'Donoghue
Journal:  Biochemistry       Date:  2022-08-18       Impact factor: 3.321

4.  The Pseudomonas aeruginosa protease LasB directly activates IL-1β.

Authors:  Josh Sun; Doris L LaRock; Elaine A Skowronski; Jacqueline M Kimmey; Joshua Olson; Zhenze Jiang; Anthony J O'Donoghue; Victor Nizet; Christopher N LaRock
Journal:  EBioMedicine       Date:  2020-09-23       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.